Deciphering the balance of IL-6/IL-10 cytokines in severe to critical COVID-19 patients.

Authors:
Azaiz MB; Jemaa AB; Sellami W; Romdhani C; Ouslati R and 3 more

Journal:
Immunobiology

Publication Year: 2022

DOI:
10.1016/j.imbio.2022.152236

PMCID:
PMC9173832

PMID:
35691133

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Immunobiology

Abbreviation: Immunobiology

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to kno…
Zelek WM; Harrison RA. (2023) - Transparency Score: 2/6
Flow cytometry profiling of cellular immune response in COVID-19 infected, recovered and vaccinated…
Kumari D; Singh S; Kumari M and 15 more (2023) - Transparency Score: 3/6
Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with …
Shete A; Deshpande S; Sawant J and 19 more (2023) - Transparency Score: 3/6
Immune cell landscape in symptomatic and asymptomatic SARS-CoV-2 infected adults and children in ur…
Akhtar E; Mily A; Sarker P and 7 more (2023) - Transparency Score: 4/6
Study of some immunological signatures and their association with COVID-19 in a sample of recovered…
Maki FM; Al-Thwani AN; Jiad KS. (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"6 Financial support This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025